The use of microbeads as an ingredient in personal care products is coming under pressure, with several governments now considering a ban of such microparticles from cosmetics, personal care and other products, and some companies undertaking voluntary bans.
The end is nigh for microbeads
How are governments worldwide moving to ban microbeads in toiletries?
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Vichy’s longevity science play addresses hair loss and zombie cells
Read moreHair renewing serum Dercos Aminexil Clinical R.E.G.E.N. Booster, and Neovadiol Longevity Revolumizing Cream for boomers, are the L’Oréal-owned dermatological brand’s first longevity-focused launches, and more are in the pipeline
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Vichy’s longevity science play addresses hair loss and zombie cells
Hair renewing serum Dercos Aminexil Clinical R.E.G.E.N. Booster, and Neovadiol Longevity Revolumizing Cream for boomers, are the L’Oréal-owned dermatological brand’s first longevity-focused launches, and more are in the pipeline
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Inside Lancôme’s strategy to become a frontrunner in longevity beauty
The L’Oréal-owned skin care player plans to become a leader in longevity beauty with its first rose-derived PDRN-inspired product and new diagnostic device which can educate consumers on their skin’s biological age like never before
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.